(Q42446999)

31 October 2017

title

Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

31 October 2017

0 references

1 reference

1 reference

1 reference

Putignano P

1

1 reference

31 October 2017

Bertolini M

series ordinal

2

1 reference

31 October 2017

Losa M

series ordinal

3

1 reference

31 October 2017

Cavagnini F

series ordinal

4

1 reference

31 October 2017

publication date

1 June 2003

1 reference

Journal of Endocrinological Investigation

31 October 2017

published in

1 reference

31 October 2017

volume

26

1 reference

31 October 2017

issue

6

1 reference

31 October 2017

page(s)

539-544

1 reference

The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03345217

Altered morning and nighttime pulsatile corticotropin and cortisol release in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345217

Diagnosis of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345217

Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345217

Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345217

Test characteristics and decision rules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345217

Measuring the accuracy of diagnostic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345217

The meaning and use of the area under a receiver operating characteristic (ROC) curve

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345217

Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome--recommendations for a protocol for biochemistry laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345217

Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345217

Polycystic Ovary Syndrome as a Form of FunctionalOvarian Hyperandrogenism Due to Dysregulation ofAndrogen Secretion*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345217

Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345217

Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345217

The effects of anti-convulsant drugs on adrenal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345217

Increased urinary free cortisol and decreased serum corticosteroid-binding globulin in polycystic ovary syndrome

21 January 2018

1 reference

12 December 2020

Late-night salivary cortisol as a screening test for Cushing's syndrome

1 reference

12 December 2020

Polycystic ovary syndrome

1 reference

12 December 2020

Variations of steroid hormone metabolites in serum and urine in polycystic ovary syndrome after nafarelin stimulation: evidence for an altered corticoid excretion

1 reference

12 December 2020

A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome

1 reference

12 December 2020

1 reference

12 December 2020

The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states

1 reference

12 December 2020

How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?

1 reference

12 December 2020

Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11 beta-hydroxysteroid dehydrogenase

1 reference

12 December 2020

5 alpha-reductase activity in polycystic ovary syndrome

1 reference

12 December 2020

The desmopressin test in the differential diagnosis between Cushing's disease and pseudo-Cushing states

1 reference

12 December 2020

The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome

1 reference

12 December 2020

Corticotropin-releasing hormone induces an exaggerated response of adrenocorticotropic hormone and cortisol in polycystic ovary syndrome

1 reference

12 December 2020

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study

1 reference

12 December 2020

A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states.

1 reference

12 December 2020

Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels

1 reference

12 December 2020

Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing's syndrome

1 reference

12 December 2020

Serum cortisol concentrations during low dose dexamethasone suppression test to screen for Cushing's syndrome

1 reference

12 December 2020

Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis

1 reference

12 December 2020

Venepuncture causes rapid rise in plasma ACTH

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03345217

1 reference

Dimensions Publication ID

31 October 2017

1024346820

0 references

1 reference